Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
about
Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosisFunctional differences between immunoglobulins M and D expressed on the surface of an immature B-cell lineImmunoglobulin receptor signaling depends on the carboxyl terminus but not the heavy-chain class.Activation-induced cell death in B lymphocytes.Activation of cyclin A-dependent protein kinases during apoptosisIdentification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity.Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.Isolation and characterization of a B lymphocyte mutant with altered signal transduction through its antigen receptorTumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphomaAntigen receptor-induced cell cycle arrest in WEHI-231 B lymphoma cells depends on the duration of signaling before the G1 phase restriction point.Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model.Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytesFrom apoptosis to autoimmunity: insights from the signaling pathways leading to proliferation or to programmed cell death.Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells.Apoptosis in B lymphocytes: the WEHI-231 perspective.CD72 stimulation modulates anti-IgM induced apoptotic signaling through the pathway of NF-kappaB, c-Myc and p27(Kip1).Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231.Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat.Expression of protein tyrosine kinases in the Ig complex of anti-mu-sensitive and anti-mu-resistant B-cell lymphomas: role of the p55blk kinase in signaling growth arrest and apoptosis.Signal transduction pathways involved in B-cell induction.Signalling function of the B-cell antigen receptors.Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells.Low and nontoxic levels of ionic mercury interfere with the regulation of cell growth in the WEHI-231 B-cell lymphoma.Antisense macrophage migration inhibitory factor (MIF) prevents anti-IgM mediated growth arrest and apoptosis of a murine B cell line by regulating cell cycle progression.Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.Withdrawal of 2-mercaptoethanol induces apoptosis in a B-cell line via Fas upregulation.Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.Fas receptor (CD95)-mediated apoptosis in leukemic cells.Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells.Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.Synergy between TGF-beta and anti-IgM in growth inhibition of CD5+ B-cell lymphomas.In vivo and in vitro assessment of B-B cell interactions: inhibition of proliferation and antibody production of the CRIA B cells mediated by the surface immunoglobulins of anti-CRIA B cells.Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation.B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity.
P2860
Q24794791-1A8444F2-F2CF-4690-8BDA-3161B9DAABA3Q24805197-6FB4B074-4EBD-4718-8751-E2DF1A216727Q28139074-0F687364-5BA3-4079-95AB-75F3CE9C44A1Q33648847-EA5D8CB3-F4A3-4E31-AFC7-DCBC1C90D4E4Q33844391-2AE96022-0DF4-4068-ADFA-4B9C31BC6967Q34060211-149F583E-4975-43EB-A6F9-2964DCD815A3Q35195381-86ABC6A7-508E-41AF-822E-4E0A73B55A37Q35631134-1D9A5146-E9EA-4DDE-87E2-6B1E0A9B208BQ35930798-C657C1D4-081B-4F2D-A761-B0B1EE97875CQ36355074-769AB0D7-05D0-4F84-BCE5-E585346A3231Q36356260-DA234196-B6CA-4C83-B574-A54D5E1D6640Q36364716-0ED10A50-919C-4C56-A7C6-2AFD4134AA99Q36501068-F0A51DB8-EF91-4D62-8BC4-38D472B5CD3DQ36711276-D7A9B4AD-D2B1-4B38-A8E2-BB700DCCF34AQ37116467-B143E29C-52EA-48CF-9FB7-039E59725729Q37380462-BD3B4139-AC20-44D4-BB68-AF9BD695C43CQ37734566-A2191AC0-DE24-4CE9-B702-03FCB4038910Q38358476-C881922E-49C3-4634-A5E4-533AA7BC55D7Q40399256-883D0AFC-8180-4430-BF2C-6897B1E82DF3Q40444736-897DA8B4-DF81-4C57-B17B-BCC65F293BD7Q40538094-5BF442D4-8926-48F6-AB30-4168ACA875BEQ40597201-6E286E92-0700-4160-9A8F-A31B6F218EDBQ40612711-6174A1E6-6B91-4A92-B5F3-4F67CFB7F238Q40736670-28E34A80-E4F4-43A9-A364-8BA50C100553Q40833868-48F3527C-76C9-427E-8D27-A4ABC5E12722Q40833877-77087650-2A48-41EE-8350-13084AEE7371Q40856698-8D5F90A6-ED73-4DA6-B482-55078CEE5E4CQ40872600-D4212C15-5697-4A97-B75B-2775B7FFE3ECQ40935320-B813B14A-8E72-4312-8B3E-831232F24286Q40963658-C774D3A8-D43C-4B47-B050-76E228631ABBQ40993369-A9C63038-9B5E-47DF-A79F-589AC97E4162Q41010121-56C489E0-9C2C-43C0-8DFD-37CBC1849E5FQ41077008-76BD344C-987B-429E-A51D-5E61BC3E506EQ41454998-9BE125E6-1BAA-49A5-B99D-4A6D064F13B4Q41821527-E81108A6-14F5-4DDB-9E31-0D479C5B5BA7Q42014888-C1310F07-02DE-4AFC-89F1-9353BFF5A218Q42057123-F6C02269-8226-436E-8446-1BA5F8A14CC5Q42676624-38B4DD48-4248-4AC2-A399-9536635E4F62Q42801468-0C02A3C0-12EF-478A-8C69-278B5312E898Q44612466-46F28EF2-CF86-454F-8977-5DDA6FD11A97
P2860
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@en
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@nl
type
label
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@en
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@nl
prefLabel
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@en
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@nl
P2093
P2860
P356
P1476
Lymphoma models for B cell act ...... 1 B lymphoma cells by anti-mu.
@en
P2093
P2860
P304
P356
10.1084/JEM.164.1.156
P407
P577
1986-07-01T00:00:00Z